DIAGNOSTIC MEDICAL SYSTEMS Diagnostic Medical Systems Stock
Equities
ALDMS
FR0012202497
Advanced Medical Equipment & Technology
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.01 EUR | 0.00% |
|
-0.98% | -11.01% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2021 | 39.99M 43.13M | Sales 2022 | 37.06M 39.97M | Capitalization | 16.28M 17.56M |
|---|---|---|---|---|---|
| Net income 2021 | -3M -3.24M | Net income 2022 | -6M -6.47M | EV / Sales 2021 | 0.78 x |
| Net Debt 2021 | 11.67M 12.59M | Net Debt 2022 | 10.98M 11.84M | EV / Sales 2022 | 0.74 x |
| P/E ratio 2021 |
-5.08
x | P/E ratio 2022 |
-2.39
x | Employees | 120 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.23% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | -0.98% | ||
| Current month | -2.42% | ||
| 1 month | -11.79% | ||
| 3 months | -12.17% | ||
| 6 months | -0.49% | ||
| Current year | -11.01% |
1 week
0.95
1.03
1 month
0.951.15
Current year
0.951.37
1 year
0.791.60
3 years
0.791.69
5 years
0.792.51
10 years
0.633.30
| Managers | Title | Age | Since |
|---|---|---|---|
Samuel Sancerni
CHM | Chairman | - | 11-09-26 |
Léone Atayi
BRD | Director/Board Member | - | - |
Nawel Naamane
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Samuel Sancerni
CHM | Chairman | - | 11-09-26 |
Regis Roche
BRD | Director/Board Member | - | - |
Léone Atayi
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 1.01 | 0.00% | 1 429 |
| 24-05-13 | 1.01 | +5.21% | 4,178 |
| 24-05-10 | 0.96 | -5.42% | 13,906 |
| 24-05-09 | 1.015 | -0.98% | 12,765 |
| 24-05-08 | 1.025 | +0.49% | 721 |
Real-time Euronext Paris, May 14, 2024 at 04:43 am EDT
More quotes
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors:
- radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities;
- development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
Products and services are marketed primarily by exclusive retailers.
Net sales (not including sold divisions) are distributed geographically as follows: Europe (62.6%), North and South America (17.7%), Asia (6.8%), Middle East (4.5%), Africa (3.8%), Oceania (1.1%) and other (3.5%).
| 1st Jan change | Capi. | |
|---|---|---|
| -11.01% | 19.21M | |
| -1.71% | 15.26B | |
| -13.40% | 2.44B | |
| -12.18% | 1.46B | |
| -.--% | 1.12B | |
| +60.60% | 591M | |
| +90.51% | 510M | |
| +13.87% | 247M | |
| +0.70% | 231M | |
| +7.22% | 194M |
- Stock Market
- Equities
- ALDMS Stock
